A Mindfulness-based Intervention for Adolescents With Prediabetes or Type 2 Diabetes
L2BT2D
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to conduct a mindfulness-based intervention for adolescents referred for prediabetes or type 2 diabetes treatment to 1) evaluate feasibility and acceptability of the intervention for future research and clinical use and 2) explore secondary health outcomes related to diabetes prevention and care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes
Started Feb 2023
Typical duration for not_applicable type-2-diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2025
CompletedFirst Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
December 8, 2025
CompletedDecember 8, 2025
November 1, 2025
1.5 years
November 14, 2025
November 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Participation
Study Participation Rate: Number of participants who consented to take part in the study divided by the number of patients approached. We will also document reasons for refusal to participate in the study.
3 months
Acceptability
L2B Program Questionnaires Post-study guided interview: 1. What did you like about participating in this study? 2. What did you dislike about participating in this study? 3. What were your expectations from participating in this study? 4. Were those expectations met?
12 months
Recruitment
Time to Recruit: Time required to attain the needed sample for each recruitment wave
3 months
Attendance
Attendance: Attendance at each intervention session will be recorded.
4 months
Retention
Study Retention Rate: Number of participants in a study arm who remain in the study and maintain communication with study staff (regardless of session attendance) divided by the number of participants enrolled in the study.
12 months
Completion
Study Completion Rate: Number of participants who complete all assessments divided by the number of participants enrolled in the study arm.
12 months
Data Completeness
Data Completeness: Percentage of questionnaires/study measures completed.
12 months
Secondary Outcomes (3)
Height from electronic medical record
12 months
HbA1c from electronic medical record
12 months
Weight from the electronic medical record
12 months
Other Outcomes (6)
Anxiety symptoms
12 months
Depression symptoms
12 months
Perceived Stress Scale
12 months
- +3 more other outcomes
Study Arms (1)
Learn to Breathe Group Program
EXPERIMENTALAll study participants take part in the L2B MBI
Interventions
L2B is a manualized 12-week curriculum that teaches a variety of mindfulness skills including breath awareness, body scanning, mindful eating, sitting meditation, loving kindness practice, and mindful movement. Weekly group sessions will last 45-60 minutes. Participants will be invited to engage in daily practice of mindfulness skills (home practice).
Eligibility Criteria
You may qualify if:
- Age 12-18 years
- Referred to clinic for treatment of prediabetes or type 2 diabetes
- English speaking
You may not qualify if:
- Diagnosed cognitive disabilities
- Inability to attend visits due to individual schedules
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riley Diabetes CLinic
Indianapolis, Indiana, 46202, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tamara S Hannon, MD
Indiana University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics
Study Record Dates
First Submitted
November 14, 2025
First Posted
December 8, 2025
Study Start
February 1, 2023
Primary Completion
July 30, 2024
Study Completion
July 30, 2025
Last Updated
December 8, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared, as the data for this study is strictly confidential.